Press "Enter" to skip to content

Evaluating innovative portfolios and preparing for branded, 505(b)(2), and generic competition

0
Listen to this article
Copyright © DrugPatentWatch. Originally published at Evaluating innovative portfolios and preparing for branded, 505(b)(2), and generic competition

Here’s a copy of the recent talk on Evaluating innovative portfolios and preparing for branded, 505(b)(2), and generic competition. It’s based on the book Make Better Decisions, which distills insights gained from more than two decades of providing guidance to biopharmaceutical companies.

Make Better Decisions with DrugPatentWatch

Try a trial or schedule a demo

Copyright © DrugPatentWatch. Originally published at Evaluating innovative portfolios and preparing for branded, 505(b)(2), and generic competition
Get email updates

Get new actionable insights and updates from DrugPatentWatch

Do NOT follow this link or you will be banned from the site!